Trial Profile
Special Drug Use-results Surveillance for long term administration of XEPLION (Paliperidone Palmitate 1 month formulation), 25mg/ 50mg/ 75mg/ 100mg/ 150mg syringe
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2020
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 21 Apr 2020 According to Janssen media release, results from this study were published in Innovations in Clinical Neuroscience on employment status and social function improvement of schizophrenic patients treated with injection (PP1M) once a month
- 21 Apr 2020 Results presented in a Janssen Media Release.
- 13 Feb 2019 Status changed from active, no longer recruiting to completed.